These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31016644)

  • 1. Mechanisms of Drug-Induced Cholestasis.
    Gijbels E; Vinken M
    Methods Mol Biol; 2019; 1981():1-14. PubMed ID: 31016644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and in vitro models of drug-induced cholestasis.
    Gijbels E; Vilas-Boas V; Deferm N; Devisscher L; Jaeschke H; Annaert P; Vinken M
    Arch Toxicol; 2019 May; 93(5):1169-1186. PubMed ID: 30972450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular bile salt transport: lessons from cholestasis.
    Trauner M; Fickert P; Stauber RE
    Can J Gastroenterol; 2000 Nov; 14 Suppl D():99D-104D. PubMed ID: 11110621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump.
    Rodrigues AD; Lai Y; Cvijic ME; Elkin LL; Zvyaga T; Soars MG
    Drug Metab Dispos; 2014 Apr; 42(4):566-74. PubMed ID: 24115749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease.
    Stieger B; Mahdi ZM
    J Pharm Sci; 2017 Sep; 106(9):2295-2301. PubMed ID: 28385542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acid transporters: structure, function, regulation and pathophysiological implications.
    Alrefai WA; Gill RK
    Pharm Res; 2007 Oct; 24(10):1803-23. PubMed ID: 17404808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools.
    de Lima Toccafondo Vieira M; Tagliati CA
    Expert Opin Drug Metab Toxicol; 2014 Apr; 10(4):581-97. PubMed ID: 24588537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholestatic liver (dys)function during sepsis and other critical illnesses.
    Jenniskens M; Langouche L; Vanwijngaerden YM; Mesotten D; Van den Berghe G
    Intensive Care Med; 2016 Jan; 42(1):16-27. PubMed ID: 26392257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Alterations of Bile Canaliculi Dynamics and the Rho Kinase/Myosin Light Chain Kinase Pathway Are Characteristics of Drug-Induced Intrahepatic Cholestasis.
    Burbank MG; Burban A; Sharanek A; Weaver RJ; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2016 Nov; 44(11):1780-1793. PubMed ID: 27538918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Let there be bile"--understanding hepatic injury in cholestasis.
    Sokol RJ; Devereaux M; Dahl R; Gumpricht E
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S4-9. PubMed ID: 16819400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.
    Yang K; Köck K; Sedykh A; Tropsha A; Brouwer KL
    J Pharm Sci; 2013 Sep; 102(9):3037-57. PubMed ID: 23653385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is cholestasis in 1985?
    Erlinger S
    J Hepatol; 1985; 1(6):687-93. PubMed ID: 3902958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular transporters and cholestasis.
    Pauli-Magnus C; Meier PJ
    J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S103-10. PubMed ID: 15758645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early indications of ANIT-induced cholestatic liver injury: Alteration of hepatocyte polarization and bile acid homeostasis.
    Yang T; Mei H; Xu D; Zhou W; Zhu X; Sun L; Huang X; Wang X; Shu T; Liu J; Ding J; Hassan HM; Zhang L; Jiang Z
    Food Chem Toxicol; 2017 Dec; 110():1-12. PubMed ID: 28986171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiology of cholestasis: correlation between bile acid metabolism and liver damage].
    Stiehl A
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():46-8. PubMed ID: 1449016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis.
    Stieger B; Geier A
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):411-25. PubMed ID: 21320040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile Acid Metabolism and Signaling in Cholestasis, Inflammation, and Cancer.
    Li T; Apte U
    Adv Pharmacol; 2015; 74():263-302. PubMed ID: 26233910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of gene expression profiles from cholestatic hepatotoxicants in vitro against human in vivo cholestasis.
    Van den Hof WFPM; Coonen MLJ; van Herwijnen M; Brauers K; Jennen D; Olde Damink SWM; Schaap FG; Kleinjans JCS
    Toxicol In Vitro; 2017 Oct; 44():322-329. PubMed ID: 28778767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical Factors in the Assessment of Cholestatic Liver Injury In Vitro.
    Woolbright BL; Jaeschke H
    Methods Mol Biol; 2015; 1250():363-76. PubMed ID: 26272158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
    Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
    Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.